ADCs Are Booming. Here’s the Data That Matters.
H1 2025 was explosive for ADCs: 400+ new entrants, a 30% spike in novel formats, and major clinical leaps. But headline numbers don’t give you the full picture, this report does.
Built from the industry’s most comprehensive ADC database, this mid-year analysis reveals what’s trending, what’s fading, and who’s really leading. If you’re scouting deals or shaping pipeline strategy, this is the intel you won’t find anywhere else.
Download your free copy today.
What’s Inside?
The Drug Landscape
A deep dive into the ADC assets added to Beacon in H1 2025, highlighting growth trends, novel ADCs, key target combinations, and emerging payload MOAs.
The Trial Landscape
Track first-in-human activity, top traditional & novel ADCs by trial phase, and key trends in trial progression and discontinuation.
The Commercial Landscape
An analysis of ADC deals from 2021–2025 by value and type, licensing activity by payload, and the global distribution of ADC-focused biopharma companies.
Regulatory Announcements
An overview of regulatory activity in H1 2025 including top drugs with the most updates and recent IND/CTA approvals.
The Future of ADCs
Forecasted growth for H2 2025, emerging targets gaining traction, and novel targets making their first appearance this year.
Previous ADC Landscape Reviews
ADC 2024 Landscape Review
ADC H1 2024 Landscape Review
You May Also Be Interested In…
Navigating Payload Innovation and Toxicity Trends in ADC Development
Access WebinarLearn More About ADC
- The Most Comprehensive Way to Search the ADC Drug Development Landscape: Unique search ontologies based on ADC drug and trial characteristics
- Market Leading Approach to ADC Preclinical & Clinical Data Curation: Manual curation of key ADC research and development data points by ADC research scientists
- Seamlessly Integrate Commercial & Scientific Data all in One Place: Search ADC company and deal data based on their pipeline and technologies.
- Unrivalled Granularity in Reports & Analysis: Our search ontology and technology indexing enable comprehensive analysis not seen elsewhere.
What is Beacon?
Beacon is a world leading data analysis tool for preclinical and clinical trial information. With unrivalled granularity of search function, data quality, and exhaustiveness, Beacon provides timely information and gives you confidence to progress your targeted drug therapies to patients.
Learn more about how our clinical trials and drug database solutions can be tailored to your research requirements
